唾液腺黏液表皮样癌的综合基因组分析揭示频发的BAP1、PIK3CA及其他可靶向基因组改变
研究对48例唾液腺黏液表皮样癌行315个癌症相关基因的综合基因组分析并计算肿瘤突变负荷。结果显示高分级肿瘤基因组改变数多于低/中分级,PI3K/mTOR通路激活在高分级更常见,BAP1和BRCA1/2改变亦被检出。作者认为这些多样的改变可能为这类罕见肿瘤提供个体化治疗选择。
要点
- 高分级肿瘤基因组改变数(均值5±3.8)多于低分级(2.3±1.4)和中分级(2.6±1.5)(P=0.019)。
- PI3K/mTOR通路激活在高分级占52%,高于低/中分级的4.3%(P=0.007)。
- BAP1改变见于20.8%肿瘤,BRCA1/2改变见于10.5%,ERBB2扩增仅8.3%。
核心结论
- 唾液腺黏液表皮样癌的综合基因组分析显示多样的基因组改变,可能为这类罕见肿瘤患者带来个体化治疗选择。
研究设计与样本
- 从48例黏液表皮样癌提取DNA,对315个癌症相关基因及28个常重排基因的内含子行杂交捕获接头连接文库的综合基因组分析,并计算肿瘤突变负荷,评估所有类型基因组改变。
主要发现
- 共在80个独特基因中发现183个基因组改变。
- 高分级肿瘤基因组改变数(均值5±3.8)多于低分级(2.3±1.4)和中分级(2.6±1.5)(P=0.019)。
- TP53改变见于所有分级(41.7%),在高分级恶性肿瘤中最常见(56%)(P=0.047)。
- CDKN2A改变见于41.6%的肿瘤。
- PI3K/mTOR通路激活(包括PIK3CA突变)在高分级占52%,高于低/中分级的4.3%(P=0.007)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We sought to identify genomic alterations (GAs) in salivary mucoepidermoid carcinomas. PATIENTS AND METHODS: DNA was extracted from 48 mucoepidermoid carcinomas. Comprehensive genomic profiling (CGP) including the calculation to tumor mutational burden (TMB) was performed on hybridization-captured adaptor ligation-based libraries of 315 cancer-related genes plus introns from 28 genes frequently rearranged for cancer and evaluated for all classes of GAs. RESULTS: A total of 183 GAs were found in 80 unique genes. High-grade tumors had more GAs (mean 5 ± 3.8) compared with low (2.3 ± 1.4) or intermediate (2.6 ± 1.5) (P = 0.019). TP53 GAs were seen in all tumor grades (41.7%) but were most common in high-grade malignancies (56%) (P = 0.047). CDKN2A GAs were seen in 41.6% of tumors. PI3K/mTOR pathway activation, including PI3KCA mutations, were more common in high grade (52%) than in low- and intermediate-grade tumors (4.3%) (P = 0.007). BAP1 GAs were observed in 20.8% of tumors and BRCA1/2 GAs present in 10.5% of specimens. ERBB2 amplifications were seen in only 8.3% of tumors. The TMB for this patient group was relatively low with only 5 (10%) of cases having greater than 10 mutations/megabase of sequenced DNA. CONCLUSION: CGP of salivary mucoepidermoid carcinomas revealed diverse GAs that may lead to customized treatment options for patients with these rare tumors.
引用
- Wang K, McDermott JD, Schrock AB, et al. Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations. Ann Oncol. 2017. PMID: 28327999. doi:10.1093/annonc/mdw689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。